Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation

Immunity

Volumn 15, Issue 4, 2001, Pages 533-543

  Ruuls, Sigrid R ^a   Hoek, Robert M ^a   Ngo, Vu N ^b   McNeil, Tom ^a   Lucian, Linda A ^a   Janatpour, Mary J ^a   Körner, Heinrich ^c   Scheerens, Heleen ^a   Hessel, Edith M ^a   Cyster, Jason G ^b   McEvoy, Leslie M ^a   Sedgwick, Jonathon D ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ALLELE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; GENE DELETION; GENE MUTATION; LYMPH FOLLICLE; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN;

EID: 17944381638     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00215-1     Document Type: Article

References (48)

1. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice
2. A chemokine-driven positive feedback loop organizes lymphoid follicles
3. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusionprotein
4. The tumour necrosis factor ligand and receptor families
5. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells
6. Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice
7. Regulation of autoimmunity by proinflammatory cytokines
8. Follicular stromal cells and lymphocyte homing to follicles
9. Cell associated tumour necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages
10. Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor
11. Biological insights from clinical trials with anti-TNF therapy
12. Development and maturation of secondary lymphoid tissue
13. Processing of tumour necrosis factor-alpha precursor by metalloproteinases
14. Tumor necrosis factor induces genes involved in inflammation, cellular and tissue repair, and metabolism in murine fibroblasts
15. Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice
16. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
17. Induction of cell death by tumor necrosis factor (TNF) receptor 2, CD40 and CD30: A role for TNF-R1 activation by endogenous membrane-anchored TNF
18. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting
19. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1
20. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: Implications for pathogenesis and therapy of autoimmune demyelination
21. TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis
22. Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue
23. Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting
24. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF
25. Gene targeting in C57BL/6 ES cells. Successful germ line transmission using recipient BALB/c blastocysts developmentally matured in vitro
26. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
27. The protective effect of IFN-gamma in experimental autoimmune diseases: A central role of mycobacterial adjuvant-induced myelopoiesis
28. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor
29. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
30. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor alpha
31. Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo
32. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen
33. Know your neighbors: Three phenotypes in null mutants of the myogenic bHLH gene MRF4
34. Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response
35. Tumor necrosis factor and the p55TNF receptor are required for optimal development of the marginal sinus and for migration of follicular dendritic cell precursors into splenic follicles
36. An essential role for ectodomain shedding in mammalian development
37. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
38. Long-range disruption of gene expression by a selectable marker cassette
39. Novel concepts of tumor necrosis factor action in autoimmune pathology
40. Unlinking tumor necrosis factor biology from the major histocompatibility complex: Lessons from human genetics and animal models
41. Characterization of chemokines and chemokine receptors in two mice models of inflammatory bowel disease: IL10-/- and Rag-2-/- mice reconstructed with CD4+CD45RBhigh T cells
42. Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts
43. Tumor necrosis factor: A master-regulator of leukocyte movement
44. The fate of pro-TNF-alpha following inhibition of metalloprotease-dependent processing to soluble TNF-alpha in human monocytes
45. The pathophysiology of tumor necrosis factors
46. CXCR5-deficient mice develop functional germinal centers in the splenic T cell zone
47. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: Requirement of the TNF receptor-associated factor-2 binding site
48. Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling